MedTrace Logo

Improving Sleep Quality After Total Joint Arthroplasty ( TJA)

NCT03879707 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2025-04-11

No results posted yet for this study

Summary

The purpose of this study is the evaluate and improve sleep quality after Total joint replacement.

Conditions

  • Pain After TJA

Interventions

DRUG

Melatonin 5 mg

Melatonin is known to induce sleep

DRUG

Placebo Oral Tablet

Placebo

DRUG

Magnesium 500Mg Oral Tablet

Magnesium plays a role in supporting deep, restorative sleep by maintaining healthy levels of GABA, a neurotransmitter that promotes sleep. Research indicates supplemental magnesium can improve sleep quality, especially in people with poor sleep

Sponsors & Collaborators

Principal Investigators

  • Derek Amanatullah, M.D. PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2028-06-30
Completion
2028-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03879707 on ClinicalTrials.gov